Evaluation Of Immunomodulatory Activity Of Meloxicam In Mice. (Record no. 3364)

000 -LEADER
fixed length control field 02249nam a2200181Ia 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20151006141425.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150525s2013 xx 000 0 und d
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 1656,T
100 ## - MAIN ENTRY--AUTHOR NAME
Personal name Ghulam Fatima
110 ## - MAIN ENTRY--CORPORATE NAME
Location of meeting Dr. Aqeel Javeed
245 ## - TITLE STATEMENT
Title Evaluation Of Immunomodulatory Activity Of Meloxicam In Mice.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Year of publication 2013
502 ## - DISSERTATION NOTE
Dissertation note In the present study, the immunomodulatory activity of meloxicam was evaluated. For the evaluation of effect of meloxicam on cellular immunity the delayed type hypersensitivity assay (DTH) and cyclophosphamide induced neutropenia assay were performed while for humoral immunity haemagglutination assay and mice lethality test was performed. In each assay 15 mice were used, all mice were divided into 3 groups, each group was consist of 5 mice. Two groups were treated with two different doses of meloxicam (5mg/kg and 10 mg/kg) and the one group (control group) was only being administered with dimethylsulphoxide (DMSO) intraperitoneally.
In DTH assay, 5mg/kg and 10mg/kg meloxicam treated groups of mice showed a significant reduction in skin thickness ( P<0.05) as compared to control group at 24hours, 48 hours and 72 hours after the challenging dose of dinitrochlorobenzene (DNCB).
In cyclophosphamide induced neutropenia assay meloxicam at 10mg/kg showed a significant percentage of reduction in total leukocytes (TLC) and two types of differential leukocytes (DLC i.e lymphocytes, and neutrophils except monocytes). This significant reduction was less in 5mg/kg meloxicam treated group which in turn was less than the control group. In addition, it was observed a dose dependent reduction response in haemagglutination (HA) titre. The order of reduction in HA titre was 10mg/kg meloxicam treated group > 5mg/kg meloxicam treated group > the control group. The mortality ratio of mice in the control group, 5mg/kg meloxicam and 10 mg/kg meloxicam treated groups was 20%, 80% and 100% respectively.
All the results of present study suggest that meloxicam has suppressive effect on cellular as well as on humoral component of immune system.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Department of Pharmaoclogy & Toxicology
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Prof. Dr. Muhammad Ashraf
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Thesis
Holdings
Damaged status Collection code Permanent Location Current Location Shelving location Date acquired Full call number Accession Number Koha item type
  Veterinary Science UVAS Library UVAS Library Thesis Section 2015-05-29 1656,T 1656,T Thesis


Implemented and Maintained by UVAS Library.
For any Suggestions/Query Contact to library or Email:rehana.kousar@uvas.edu.pk Phone:+91 99239068
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.